Skip to main content
Clinical Trials/CTRI/2025/05/086136
CTRI/2025/05/086136Not yet recruitingPhase 2/3

Comparison of caudal clonidine versus caudal dexmedetomidine with bupivacaine for prolongation of postoperative analgesia in children undergoing infraumbilical surgeries.

NIRMALKUMAR MISTRY1 site in 1 country60 target enrollmentStarted: May 10, 2025Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
1.TO COMPARE DURATION OF ANALGESIA IN BOTH GROUP.

Study Overview

Brief Summary

Bupivacaine is a long acting amide local anaesthetic. It is most frequently used for caudal anaesthesia in children that provides effective analgesia and motor blockade.Clonidine has been used for sedation, premedication and analgesia.Dexmedetomidine is a potent alpha 2 agonist (selective 2a subtype), widely used to provide analgesia, sedation and anxiolysis.Studies show increase in duration of post-operative analgesia on adding clonidine  & dexmedetomidine to local anaesthetic. Both are a safe adjuvant to bupivacaine in pediatric caudal anaesthesia.We therefore decided to study the effects of combination of Bupivacaine and clonidine for prolongation of post-operative analgesia in children were evaluated and compared with the effect of combination of bupivacaine and Dexmedetomidine for prolongation of post-operative analgesia. Hemodynamic changes and side effects  was also compared between both group, in children undergoing lower abdominal and perineal surgeries.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
1.00 Year(s) to 8.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • ASA I ,II AND III PATIENTS SCHEDULED FOR INFRA-UMBILICAL SURGERIES ELECTIVE SURGERIES.
  • CONSENT FROM LEGALLY AUTHORIZED REPRESENTATIVE.

Exclusion Criteria

  • ASA IV AND V PARENTS AND PATIENT RELATIVE REFUSING TO GIVE CONSENT PATIENTS HAVING PRE-EXISTING CARDIAC, NEUROLOGICAL AND RESPIRATORY DISEASES PATIENTS HAVING COAGULOPATHY PATIENTS WITH CONGENITAL SPINE ANOMALY LOCAL INFECTION/INFLAMMATION.

Outcomes

Primary Outcomes

1.TO COMPARE DURATION OF ANALGESIA IN BOTH GROUP.

Time Frame: 24 HR POST OPERATIVE ASSESSMENT OF PAIN RELIEF SCORE.

2.TO STUDY POSTOPERATIVE PAIN RELIEF IN BOTH GROUP.

Time Frame: 24 HR POST OPERATIVE ASSESSMENT OF PAIN RELIEF SCORE.

Secondary Outcomes

  • 1.INTRAOPERATIVE HEMODYNAMIC PARAMETERS.(2.TO COMPARE INTRA OPERATIVE AND POSTOPERATIVE COMPLICATIONS RELATED TO DRUG AND COMPLICATION ASSOCIATED WITH TECHNIQUE.)

Investigators

Sponsor
NIRMALKUMAR MISTRY
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

NIRMALKUMAR MISTRY

B.J. MEDICAL COLLEGE AHMEDABAD

Study Sites (1)

Loading locations...

Similar Trials